Concordia International (formerly AMCo) is a diverse, international pharmaceutical company focused on legacy medicines and orphan drugs. We have a strong international footprint with sales in more than 100 countries, and a diversified portfolio of more than 200 well-established off-patent molecules. We supply niche medicines that make a real difference to the patients, doctors, hospitals and healthcare authorities we serve. We are building our portfolio of medicines through acquisition, in-licensing and internal developments. In the UK we contribute actively to a highly effective generics industry which is estimated to save the UK's NHS c.£13.5 billion pounds in healthcare costs each year (source: British Generic Manufacturers Association) .

Website: concordiarx.com

Employees: 250 - 499

HQ: 905-842-5150

Location: Valley Stream, NY, US

Revenue: 500 Million - 1 Billion

Are you looking for contact information for Concordia International Forwarding Corp? Look no further! ConnectPlex is the perfect place to find and connect with people working at Concordia International Forwarding Corp. Our AI-based B2B lead generation products provide you with the most up-to-date and accurate contact information for businesses worldwide, including Concordia International Forwarding Corp. Reach out to us, and we'll help you connect with the right people to grow your business. At ConnectPlex, we understand the importance of having access to reliable contact information. That's why we've developed our products to provide you with the most comprehensive and accurate data possible. Our company information includes millions of companies across the globe, and we're confident that we can help you find the contact details you need for Concordia International Forwarding Corp. Let us help you take your business to the next level!

Concordia International Forwarding Corp is a leading provider of warehousing and logistics services, specializing in freight transportation arrangement and customized consolidation services. With a strong international footprint and a diversified portfolio of over 200 well-established off-patent molecules, the company is focused on legacy medicines and orphan drugs. Concordia International has a robust presence in the UK, where it contributes actively to a highly effective generics industry, estimated to save the NHS £13.5 billion pounds in healthcare costs each year. The company's commitment to quality and reliability is reflected in its CCSF (Certified Cargo Screening Facilities) certification for all USA offices, ensuring the highest level of security and safety in its operations. With a team of experienced professionals and a state-of-the-art infrastructure, Concordia International Forwarding Corp is well-equipped to meet the diverse needs of its clients, providing tailored solutions that exceed expectations.

Concordia International is a global pharmaceutical company that focuses on developing and providing medicines that are no longer under patent protection. We sell our medicines in over 100 countries and have a wide range of products that are well-established and trusted by doctors, hospitals, and healthcare providers. Our medicines are often used to treat rare or neglected diseases, and we are constantly working to expand our portfolio through acquisitions, partnerships, and internal research and development. In the UK, our contributions to the generics industry help save the National Health Service (NHS) approximately £13.5 billion each year, according to the British Generic Manufacturers Association.